We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Population-based age- and sex-specific percentiles showing 30-year absolute risk estimates for cardiovascular disease, atherosclerotic cardiovascular disease (ASCVD) and heart failure (HF) based on ...

Based on the PREVENT risk calculator, researchers developed age- and sex-specific percentiles for 30-year absolute risk estimates for cardiovascular disease. Framing risk relative to peers by age and ...

Background Recent cardiovascular risk equations from the USA and United Kingdom use routinely collected electronic medical records (EMRs), while current equations used in Australia (AusCVDRisk) have ...

A cardiologist recently suggested that I should consider taking a statin because of my “borderline” cholesterol level. So, I took a dive into the details of statin therapy. I learned that although ...

NEW ORLEANS, LA—A PCSK9 inhibitor used on top of lipid-lowering therapy, including a high-intensity statin, significantly cuts the risk of major adverse cardiovascular events compared with placebo ...

The fintech roller coaster—after a few years of barrel rolls and corkscrews—is on a solid upward swing, says Immad Akhund, fintech Mercury’s cofounder and CEO. “It’s been a real roller coaster,” he ...

CEO Corey Thomas reported Rapid7 ended the third quarter with $838 million in ARR, growing 2% year-over-year, while acknowledging ongoing timing variability within large deal pipelines. Thomas stated, ...

There was a time when fourth down meant one thing— punt and play it safe. Lately, that’s changed. More coaches are going for it and use data to help them decide. As a result, plays that used to be ...

DEAR DR. ROACH: A cardiologist recently suggested that I should consider taking a statin because of my “borderline” cholesterol level. So, I took a dive into the details of statin therapy. I learned ...

A newer tool used to assess cardiovascular disease risk comes with both answers…and some questions. “These results were not surprising to us,” investigators Adam Bress, PharmD, MS, and Catherine ...

PLAINSBORO, N.J. and BAGSVÆRD, Denmark, Oct. 17, 2025 /PRNewswire/ -- Novo Nordisk announced today that the US Food and Drug Administration (FDA) has approved Rybelsus®, the only oral GLP-1 medication ...